IPP Bureau
Boehringer Ingelheim launches next generation poultry vaccine in India
By IPP Bureau - November 26, 2024
This is recommended for in-ovo vaccination of 18 to 19-day-old embryonated chicken eggs and one-day old chickens to protect against the virulent Marek’s disease
Merck announces pivotal phase 3 ZENITH trial evaluating WINREVAIR
By IPP Bureau - November 26, 2024
WINREVAIR met primary endpoint of time to first morbidity or mortality event for the treatment of patients with pulmonary arterial hypertension (PAH) functional class III or IV at high risk of mortality
Lonza announces first GMP batch completion at next-generation mammalian manufacturing facility in US
By IPP Bureau - November 25, 2024
First GMP batch released at Lonza’s next-generation mammalian manufacturing facility in Portsmouth (US)
Surendralal Karsanbhai elected to Merck Board of Directors
By IPP Bureau - November 25, 2024
With the addition of Karsanbhai, the Merck board will consist of 13 members
.jpg "Sourav Ganguly launches Beurer India's GL 22 Blood Glucose Monitor")
Sourav Ganguly launches Beurer India's GL 22 Blood Glucose Monitor
By IPP Bureau - November 25, 2024
The GL 22 Blood Glucose Monitor combines German precision with advanced technology designed to meet local needs
USFDA accepts Blenrep combinations for treatment of relapsed/refractory multiple myeloma
By IPP Bureau - November 25, 2024
If approved, Blenrep (belantamab mafodotin) in combinations with BorDex (BVd) and PomDex (BPd) could redefine multiple myeloma treatment at or after first relapse
Amalgamation of Gujarat Themis Biosyn with Themis Medicare
By IPP Bureau - November 23, 2024
The Scheme is subject to approval of the secured creditors and shareholders of TML and GTBL
AstraZeneca Pharma Pharma India to launch Breztri Aerosphere in Jan 2025
By IPP Bureau - November 23, 2024
IMCD expands its Pharmaceuticals Technical Centre in Jakarta
By IPP Bureau - November 23, 2024
The centre features a cutting-edge climatic chamber for stability testing and spectrophotometry to ensure that products meet the most stringent manufacturing and testing standards
Merck recommends rejection of TRC Capital’s “Mini-Tender” Offer
By IPP Bureau - November 23, 2024
The offer price is approximately 4.32% below the closing price of the Merck common stock on November 11, 2024
JHU signs MoU with Ajit Isaac Foundation to bring essential palliative care services to rural India’s terminally ill
By IPP Bureau - November 22, 2024
The collaboration offers opportunities for training, research fellowships, workshops and conferences at palliative care centers managed by Ajit Isaac Foundation
Sartorius Stedim Biotech opens center for bioprocess innovation in USA
By IPP Bureau - November 22, 2024
New research labs and process development services to enable next generation therapeutics
Strides Pharma Science appoints Dr. C. Muthulingam as Executive VP - R&D
By IPP Bureau - November 22, 2024
Dr. Muthu was last associated with Mankind Pharma
Merck Life Science India ink MoU with GeNext Genomics
By IPP Bureau - November 22, 2024
Genext Genomics can now offer comprehensive solutions that support the growth of India’s biotech ecosystem
